Literature DB >> 6690682

Trypanocidal 1,3-arylene diketone bis(guanylhydrazone)s. Structure-activity relationships among substituted and heterocyclic analogues.

P Ulrich, A Cerami.   

Abstract

Based on the antitrypanosomal activity of 1,3-diacetylbenzene bis(guanylhydrazone) (4) and 2,6-diacetylpyridine bis(guanylhydrazone) (17), a number of substituted and heterocyclic 1,3-arylene diketone bis(guanylhydrazone)s were prepared and tested against Trypanosoma brucei infections in mice. A wide range of ED50 values was observed among 5-substituted derivatives of 4. The 5-amino analogue 5 and 5-acetamido analogue 6 were about twice as active as 4. 1,3,5-Triacetylbenzene tris(guanylhydrazone) (12) was about 9 times as active as 4 and was approximately one-half as active as the currently used trypanocide diminazene aceturate in this test system. Other 5-derivatives had activity equivalent to or less than that of the parent compound 4. Three new heterocyclic analogues were all less active than 2,6-diacetylpyridine derivative 17 and benzene derivative 4. Ring substitution ortho to the guanylhydrazone side chains was invariably detrimental to activity. Side-chain homologues 1,3-dipentanoylbenzene bis(guanylhydrazone) and 1,3-diacetylbenzene bis(2-imidazolin-2-ylhydrazone) were essentially inactive.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6690682     DOI: 10.1021/jm00367a007

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  12 in total

1.  Efficacy of experimental trypanocidal compounds against a multiple drug-resistant Trypanosoma brucei brucei stock in mice.

Authors:  E Zweygarth; D Röttcher
Journal:  Parasitol Res       Date:  1989       Impact factor: 2.289

2.  Characterization of Trypanosoma brucei brucei S-adenosyl-L-methionine decarboxylase and its inhibition by Berenil, pentamidine and methylglyoxal bis(guanylhydrazone).

Authors:  A J Bitonti; J A Dumont; P P McCann
Journal:  Biochem J       Date:  1986-08-01       Impact factor: 3.857

3.  New furin inhibitors based on weakly basic amidinohydrazones.

Authors:  Frank Sielaff; Manuel E Than; Dorian Bevec; Iris Lindberg; Torsten Steinmetzer
Journal:  Bioorg Med Chem Lett       Date:  2010-11-25       Impact factor: 2.823

4.  Evaluation of deoxyhypusine synthase inhibitors targeting BCR-ABL positive leukemias.

Authors:  Patrick Ziegler; Tuhama Chahoud; Thomas Wilhelm; Nora Pällman; Melanie Braig; Valeska Wiehle; Susanne Ziegler; Marcus Schröder; Chris Meier; Adrian Kolodzik; Matthias Rarey; Jens Panse; Joachim Hauber; Stefan Balabanov; Tim H Brümmendorf
Journal:  Invest New Drugs       Date:  2012-03-14       Impact factor: 3.850

5.  Guanylhydrazones in therapy of Pneumocystis carinii pneumonia in immunosuppressed rats.

Authors:  P D Walzer; J Foy; J Runck; P Steele; M White; R S Klein; B A Otter; R J Sundberg
Journal:  Antimicrob Agents Chemother       Date:  1994-11       Impact factor: 5.191

6.  An inhibitor of macrophage arginine transport and nitric oxide production (CNI-1493) prevents acute inflammation and endotoxin lethality.

Authors:  M Bianchi; P Ulrich; O Bloom; M Meistrell; G A Zimmerman; H Schmidtmayerova; M Bukrinsky; T Donnelley; R Bucala; B Sherry
Journal:  Mol Med       Date:  1995-03       Impact factor: 6.354

7.  Nuclear localization signal of HIV-1 as a novel target for therapeutic intervention.

Authors:  L Dubrovsky; P Ulrich; G J Nuovo; K R Manogue; A Cerami; M Bukrinsky
Journal:  Mol Med       Date:  1995-01       Impact factor: 6.354

8.  Cationic antitrypanosomal and other antimicrobial agents in the therapy of experimental Pneumocystis carinii pneumonia.

Authors:  P D Walzer; C K Kim; J Foy; M J Linke; M T Cushion
Journal:  Antimicrob Agents Chemother       Date:  1988-06       Impact factor: 5.191

9.  Cure of Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense infections in mice with an irreversible inhibitor of S-adenosylmethionine decarboxylase.

Authors:  A J Bitonti; T L Byers; T L Bush; P J Casara; C J Bacchi; A B Clarkson; P P McCann; A Sjoerdsma
Journal:  Antimicrob Agents Chemother       Date:  1990-08       Impact factor: 5.191

Review 10.  Treatment of experimental pneumocystosis: review of 7 years of experience and development of a new system for classifying antimicrobial drugs.

Authors:  P D Walzer; J Foy; P Steele; M White
Journal:  Antimicrob Agents Chemother       Date:  1992-09       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.